Lindbrook Capital, LLC Novo Cure LTD Transaction History

Lindbrook Capital, LLC

$1.09 Billion
Q4 2024

A detailed history of Lindbrook Capital, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Lindbrook Capital, LLC holds 1,854 shares of NVCR stock, worth $40,435. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,854

Previous 641 189.24%

Holding current value

$40,435

Previous $10,000 450.0%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$14.54 - $33.41 $17,637 - $40,526	1,213 Added 189.24%	1,854 $55,000
Q3 2024 Nov 01, 2024	SELL	$15.61 - $23.34 $1,498 - $2,240	-96 Reduced 13.03%	641 $10,000
Q2 2024 Jul 31, 2024	SELL	$11.83 - $24.05 $686 - $1,394	-58 Reduced 7.3%	737 $12,000
Q1 2024 Apr 25, 2024	BUY	$12.42 - $17.29 $5,539 - $7,711	446 Added 127.79%	795 $12,000
Q4 2023 Jan 31, 2024	SELL	$11.13 - $15.78 $1,257 - $1,783	-113 Reduced 24.46%	349 $5,000
Q3 2023 Oct 25, 2023	SELL	$16.15 - $42.35 $1.24 Million - $3.24 Million	-76,506 Reduced 99.4%	462 $7,000
Q2 2023 Jul 28, 2023	BUY	$40.29 - $82.51 $979,006 - $2 Million	24,299 Added 46.14%	76,968 $3.19 Million
Q1 2023 Apr 26, 2023	BUY	$56.44 - $118.81 $130,658 - $275,045	2,315 Added 4.6%	52,669 $3.17 Million
Q4 2022 Jan 24, 2023	BUY	$63.98 - $85.37 $3.21 Million - $4.28 Million	50,183 Added 29346.78%	50,354 $0
Q3 2022 Nov 10, 2022	BUY	$67.99 - $89.57 $8,498 - $11,196	125 Added 271.74%	171 $13,000
Q2 2022 Aug 01, 2022	SELL	$56.6 - $89.9 $283 - $449	-5 Reduced 9.8%	46 $3,000
Q1 2022 Apr 21, 2022	BUY	$60.15 - $84.52 $2,466 - $3,465	41 Added 410.0%	51 $4,000
Q4 2021 Jan 18, 2022	SELL	$75.08 - $121.99 $6,006 - $9,759	-80 Reduced 88.89%	10 $1,000
Q3 2021 Nov 05, 2021	SELL	$116.17 - $194.55 $6,157 - $10,311	-53 Reduced 37.06%	90 $10,000
Q2 2021 Jul 27, 2021	BUY	$130.4 - $225.58 $1,695 - $2,932	13 Added 10.0%	143 $32,000
Q1 2021 Apr 28, 2021	BUY	$124.11 - $190.17 $3,102 - $4,754	25 Added 23.81%	130 $17,000
Q4 2020 Jan 27, 2021	BUY	$112.16 - $174.14 $560 - $870	5 Added 5.0%	105 $18,000
Q3 2020 Nov 03, 2020	BUY	$58.05 - $111.31 $1,451 - $2,782	25 Added 33.33%	100 $11,000
Q2 2020 Jul 27, 2020	BUY	$57.2 - $74.41 $4,290 - $5,580	75 New	75 $4,000
Q1 2019 Apr 23, 2019	SELL	$31.96 - $56.12 $0 - $0	0 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$28.72 - $52.63 $0 - $0	0 New	0 $0

Others Institutions Holding NVCR

# of Institutions

289

Shares Held

75.6M

Call Options Held

1.77M

Put Options Held

538K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.29B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Novo Cure LTD Transaction History